↓ Skip to main content

Dove Medical Press

Article Metrics

What is this page? Embed badge

Targeting the hypoxia pathway to treat pancreatic cancer

Overview of attention for article published in Drug Design, Development and Therapy, April 2015
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
24 Dimensions

Readers on

mendeley
25 Mendeley
Summary Twitter Dimensions citations
Title
Targeting the hypoxia pathway to treat pancreatic cancer
Published in
Drug Design, Development and Therapy, April 2015
DOI 10.2147/dddt.s80888
Pubmed ID
25897209
Authors

Jun Zhang, Lori Erickson, Edward Highsmith Jr., Peiwen Fei

Abstract

The correlation between hypoxia and pancreatic cancer has long been discussed. Hao's research team made many efforts on revealing the oncogenic function of hypoxic inducible factor-1 (HIF-1) in pancreatic cancer progression and development in recent years. Based on their research, they linked micro-environmental regulation of pancreatic cancer and its clinical significance. Hao's research team suggests it is a promising approach to target HIF-1 for the management of pancreatic cancer progression and invasion.

View on publisher site

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 25 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 25 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 6 24%
Researcher 5 20%
Student > Master 4 16%
Student > Bachelor 2 8%
Other 2 8%
Other 2 8%
Unknown 4 16%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 7 28%
Agricultural and Biological Sciences 4 16%
Medicine and Dentistry 4 16%
Pharmacology, Toxicology and Pharmaceutical Science 3 12%
Computer Science 1 4%
Other 2 8%
Unknown 4 16%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 April 2015.
All research outputs
#20,273,512
of 22,805,349 outputs
Outputs from Drug Design, Development and Therapy
#1,578
of 2,083 outputs
Outputs of similar age
#224,025
of 264,596 outputs
Outputs of similar age from Drug Design, Development and Therapy
#56
of 82 outputs
Altmetric has tracked 22,805,349 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,083 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.2. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 264,596 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 82 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.

This page is hosted by Altmetric on behalf of Dove Medical Press.